For the Inventor, By the Inventor

Enter inventor name

John Cameron Bell

USPTO Granted Patents = 30 (Patent Applications = 23)

CIPO Patents = 9 (Patent Applications = 12)

EPO Patents = 13 (Patent Applications = 22)

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 68(Granted Patents)

Location History:

Ontario, CA (2012)
Ottawa, CA (2007 - 2023)

Company Filing History:

Turnstone Limited Partnership

Ottawa Hospital Research Institute

Sillajen Biotherapeutics, Inc.

Wellstat Biologics Corporation

Robarts Research Institute

8. 1 out of 163

University of Ottawa

Children's Hospital of Eastern Ontario Research Institute Inc.

Turnstone Biologics Corp.

11. 1 out of 2,328

where one patent can have more than one assignee

Years Active: 2007-2023

Loading Chart...

Loading Chart...

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11802292 - Modified orthopoxvirus vectors (2023-10-31),

2. 11739350 - MicroRNA-based compositions and methods used in disease treatment (2023-08-29),

3. 11590184 - Oncolytic rhabdovirus expressing IL12 (2023-02-28),

4. 11110138 - Non-replicating virus-derived particles and uses thereof (2021-09-07),

5. 10767166 - Methods and compositions for production of vaccina virus (2020-09-08),

6. 10660947 - Vaccine composition (2020-05-26),

7. 10646557 - Vaccine composition (2020-05-12),

8. 10604741 - Compositions and methods for enhancing virus replication (2020-03-31),

9. 10603351 - Engineered synergistic oncolytic viral symbiosis (2020-03-31),

10. 10434169 - Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus (2019-10-08),

11. 10363293 - Vaccine composition (2019-07-30),

12. 10202581 - Methods and compositions for production of vaccinia virus (2019-02-12),

13. 10066214 - Compositions and methods for enhancing virus replication (2018-09-04),

14. 9919047 - Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus (2018-03-20),

15. 9896664 - Oncolytic rhabdovirus (2018-02-20),

Title: John Cameron Bell - Pioneering Inventor from Ottawa, CA

Introduction: John Cameron Bell is a renowned inventor based in Ottawa, Canada, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: John Cameron Bell holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With over two decades of experience in the industry, John Cameron Bell has successfully brought numerous inventions from concept to market, revolutionizing the way we approach modern challenges.

Collaborations: Throughout his career, John Cameron Bell has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge exchange.

Conclusion: John Cameron Bell's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…